Cat. No.: HY-N0055

Chlorogenic acid

(Synonyms: 3-O-Caffeoylquinic acid; Heriguard; NSC-407296)

36 Cited Publications

고객리뷰

Based on 36 publication(s) in Google Scholar

Chlorogenic acid is a major phenolic compound in Lonicera japonica Thunb. It is an orally active antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension compound.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Purity: 99.53%
CAS No.: 327-97-9
화학식: C₁₆H₁₈O₉
분자량:354.31

보관:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months

Chlorogenic acid Chemical Structure

CAS No.: 327-97-9

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- Cellular Effect
- In Vitro
- In Vivo
- Clinical Trial
Chemical Information
Publications (36)
용액&용해도
- In Vitro
- In Vivo
순도&문서
References
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

All HIF/HIF Prolyl-Hydroxylase Isoforms :

All Endogenous Metabolite Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
BALB/3T3	IC₅₀	>280 μM Compound: 14	Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay	[PMID: 10096863]
BMDC	IC₅₀	>50 μM Compound: 4	Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA	[PMID: 25769817]
BMDC	IC₅₀	>50 μM Compound: 4	Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA	[PMID: 25769817]
BMDC	IC₅₀	>50 μM Compound: 4	Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA	[PMID: 25769817]
BMDM	IC₅₀	86 μM Compound: Chlorogenic acid	Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-base Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-base	[PMID: 31257875]
HCT-116	IC₅₀	367 μM Compound: chlorogenic acid	Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay	[PMID: 12880319]
HeLa	IC₅₀	>200 μM Compound: Chlorogenic acid	Inhibition of HDAC in human HeLa cells using Boc-Lys(AC)-AMC as substrate after 24 to 48 hrs by spectrofluorometry Inhibition of HDAC in human HeLa cells using Boc-Lys(AC)-AMC as substrate after 24 to 48 hrs by spectrofluorometry	[PMID: 26996372]
HeLa	IC₅₀	375 μM Compound: 26	Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay	[PMID: 19520580]
MT2	ED₅₀	>497 μM Compound: chlorogenic acid	Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells	[PMID: 9986720]
SW480	IC₅₀	353 μM Compound: chlorogenic acid	Cytotoxicity against human SW480 cells after 72 hrs by MTT assay Cytotoxicity against human SW480 cells after 72 hrs by MTT assay	[PMID: 12880319]

In Vitro

Chlorogenic acid (10 μM, 16 h) decreases HIF-1α protein levels in CoCl₂ induced hypoxic A549 cells, but does not affect HIF-1α mRNA level^[1].
Chlorogenic acid (10 μM, 24 h) inhibits the hypoxia-induced HUVEC cell migration, invasion and tube formation of vascular endothelial cells^[1].
Chlorogenic acid (25, 50 μM, 24 h) inhibits cell proliferation of Huh7 cells, and reduces the number of invading and migrating cells^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Chlorogenic acid (10 μM, s.c.) inhibits VEGF (200 ng/mL)-induced angiogenesis in C57BL/6J mice, by suppression of AKT activation (Matrigel plug assay)^[1].
Chlorogenic acid (10-100 mg/kg, p.o.) shows protective effects against experimental reflux esophagitis in rats^[3].
Chlorogenic acid (10 mg/kg, i.v.) prevents endotoxic mortality and induced TNF-α release of LPS-intoxicated C57BL/6 mice, and ameliorates acute liver injury of LPS/GalN-challenged mice^[2].
Chlorogenic acid (ip, 25-200 mg/kg) inhibits tumor growth in NOD/SCID mice inoculated with Huh7 or H446 cells^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Experimental reflux esophagitis (RE) in rats^[1]
Dosage:

10, 30, 100 mg/kg
Administration:

p.o.
Result:

Reduced esophageal lipid peroxidation (marker: MDA) and increased the reduced glutathione/oxidized glutathione ratio.
Inhibited the increases in the serum level of TNF-α, and expressions of iNOS and COX-2 protein.

Animal Model:

LPS/GalN-challenged mice^[2]
Dosage:

10 mg/kg
Administration:

i.v.
Result:

Increased survival rates of LPS/GalN-intoxicated mice.
Inhibited LPS/GalN-induced phosphorylation of NF-κB p65 or c-Jun, without affecting p-IRF3 levels in the liver lobules.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

Chemical Information

CAS No. 327-97-9
Appearance Solid
분자량 354.31
화학식 C₁₆H₁₈O₉
Color Off-white to light brown
SMILES

O=C([C@@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@H](O)[C@H](O)C1)O
Synonyms

3-O-Caffeoylquinic acid; Heriguard; NSC-407296
Structure Classification
- Phenylpropanoids
- Simple Phenylpropanols
- Phenols
- Polyphenols
Initial Source
- Endogenous metabolite
- Human Gut Microbiota Metabolites
- Microorganisms
선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	1 year
	-20°C	6 months

Publications (36)

All Bio/Physico-chemical AssayGel ElectrophoresisWBHistological Imaging/StainingIHC

Sort by:

Journal Impact Factor

Nat Commun

Structural basis for transport and inhibition of the human glucose-6-phosphate transporter G6PT. [Abstract]

2025 Oct 24;16(1):9420. PMID: 41136424
Engineering

2026 May 20.
J Hazard Mater

Ammonia-induced exosomal miRNA disrupts autophagy and promotes lung injury: Therapeutic potential of natural compounds. [Abstract]

2026 Mar 15:506:141417. PMID: 41775203
J Hazard Mater

Characterization of metalaxyl-induced notochord toxicity based on biochemical and transcriptomics in zebrafish (Danio rerio) model. [Abstract]

2025 Mar 15:486:136985. PMID: 39764961
Food Chem

Comparison of binding interaction between β-lactoglobulin and three common polyphenols using multi-spectroscopy and modeling methods. [Abstract]

2017 Aug 1:228:143-151. PMID: 28317707
Nat Struct Mol Biol

Structural basis of glucose-6-phosphate transport by human SLC37A2. [Abstract]

2025 Nov 12. PMID: 41225050
Int J Biol Macromol

Comparative studies of interaction of β-lactoglobulin with three polyphenols. [Abstract]

2019 Sep 1:136:804-812. PMID: 31228500
Antioxidants (Basel)

Bioactive Extracts and Constituents from Taraxacum mongolicum: Antioxidant, Anti-Inflammatory, Enzyme-Inhibitory, and Molecular Docking Studies. [Abstract]

2026 May 29;15(6):688. PMID: 42351994
Phytother Res

Chlorogenic acid improves diabetic retinopathy by alleviating blood-retinal-barrier dysfunction via inducing Nrf2 activation. [Abstract]

2022 Mar;36(3):1386-1401. PMID: 35133045
Cell Rep Phys Sci

2024 Sep 18.
J Agric Food Chem

Chemoproteomic Profiling of Cobalamin-Independent Methionine Synthases in Plants with a Covalent Probe. [Abstract]

2020 Jul 29;68(30):8050-8056. PMID: 32618189

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056. [Abstract]

Dose-dependent inhibition of AtMS1 activity by Chlorogenic acid (10, 20, 50, 100, 200 μM).

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056. [Abstract]

Gel-based competitive labeling of recombinant AtMS1 with various small molecules as competitors. Chlorogenic acid (100 μM) significantly reduce probe labeling.

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056. [Abstract]

Dose-dependent inhibition of G1-yne labeling of AtMS1 by Chlorogenic acid (10, 20, 50, 100, 200 μM)
Life Sci

Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis. [Abstract]

2020 Aug 1:254:117590. PMID: 32220624

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1:254:117590. [Abstract]

Hematoxylin and eosin (H&E) stained micrographs of histological features of rat bladder sections. There was a significant amelioration of injury and inflammation in the IC + CGA group after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1:254:117590. [Abstract]

IHC assays were used to detect the expression of the inflammatory markers IL-6, IL-1β, TNF-α, and NF-κB in bladder tissues was decreased after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1:254:117590. [Abstract]

Western blot results show the expression levels of IL6, IL-1β, and TNF-α was decreased after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.
Pharm Biol

Chlorogenic acid promotes angiogenesis and attenuates apoptosis following cerebral ischaemia-reperfusion injury by regulating the PI3K-Akt signalling. [Abstract]

2022 Dec;60(1):1646-1655. PMID: 35981220
Eur J Pharmacol

Exploring the effect of chlorogenic acid on oxidative stress and autophagy in dry eye mice via the AMPK/ULK1 pathway. [Abstract]

2025 Mar 15:991:177311. PMID: 39892448
Front Cell Dev Biol

Licarin-B Exhibits Activity Against the Toxoplasma gondii RH Strain by Damaging Mitochondria and Activating Autophagy. [Abstract]

2021 Jun 11:9:684393. PMID: 34179016
J Nutr Biochem

Food-derived chlorogenic acid prevents aortic aneurysm and dissection by nutritional restore branched-chain amino acid dyshomeostasis. [Abstract]

2026 Apr:150:110211. PMID: 41360205
Molecules

Chlorogenic Acid Attenuates Isoproterenol Hydrochloride-Induced Cardiac Hypertrophy in AC16 Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway. [Abstract]

2024 Feb 7;29(4):760. PMID: 38398512
Sci Rep

Chlorogenic acid protects against myocardial ischemia-reperfusion injury in mice by inhibiting Lnc Neat1/NLRP3 inflammasome-mediated pyroptosis. [Abstract]

2023 Oct 18;13(1):17803. PMID: 37853132
Pestic Biochem Physiol

Mechanistic insights into chlorogenic acid and caffeic acid as novel juvenile hormone antagonists. [Abstract]

2025 Dec:215:106655. PMID: 41162045
Microorganisms

Chlorogenic Acid Ameliorates CVB3-Induced Viral Myocarditis by Suppressing Viral Replication and ZBP1-Mediated PANoptosis. [Abstract]

2026 Jun 21;14(6):1375. PMID: 42354999
J Cell Mol Med

Jinbei Decoction Attenuates LPS-Induced Acute Lung Injury via Suppression of TRAF6-Dependent Inflammatory Response in Macrophage. [Abstract]

2025 Nov;29(21):e70944. PMID: 41230791
Aquat Toxicol

Chlorogenic acid alleviates thioacetamide-induced toxicity and promotes liver development in zebrafish (Danio rerio) through the Wnt signaling pathway. [Abstract]

2022 Jan:242:106039. PMID: 34856462
J Inflamm Res

Chinese Herbal Medicine Suyin Detoxification Granule Inhibits Pyroptosis and Epithelial-Mesenchymal Transition by Downregulating MAVS/NLRP3 to Alleviate Renal Injury. [Abstract]

2021 Dec 7;14:6601-6618. PMID: 34908861
Fish Shellfish Immunol

Emodin enhances host antiviral immunity against Micropterus salmoides rhabdovirus by activating RLR signaling in largemouth bass. [Abstract]

2025 Nov:166:110633. PMID: 40769268
Neurotox Res

Tubuloside B Alleviates Aβ25-35 Induced PC12 Cell Injury by Attenuating Pyroptosis, Apoptosis and Excessive Autophagy. [Abstract]

2026 Mar 19;44(2):12. PMID: 41854817
Aquac Rep

2026 Mar 25.
J Leukoc Biol

Mechanism of chlorogenic acid in alveolar macrophage polarization in Klebsiella pneumoniae-induced pneumonia. [Abstract]

2022 Jul;112(1):9-21. PMID: 34585429
Cell Biochem Biophys

Suyin Detoxification Prescription Regulates the Klotho and ERK/NF-κB Signaling Pathways to Alleviate Renal Injury. [Abstract]

2025 Feb 18. PMID: 39966333
Vet Microbiol

The Chinese medicine monomer Schisandrin C inhibits PRRSV infection by regulating the OGT-PI3K/AKT/mTOR signaling pathway. [Abstract]

2026 May:316:110992. PMID: 41865607
Plant Pathol

2025 Dec 30.
Int J Med Microbiol

Anti-inflammatory effect of chlorogenic acid in Klebsiella pneumoniae-induced pneumonia by inactivating the p38MAPK pathway. [Abstract]

2023 Mar;313(2):151576. PMID: 36812841

Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Int J Med Microbiol. 2023 Mar;313(2):151576. [Abstract]

Chlorogenic acid (CGA; 50 μg/mL; 1 h) inhibits the Klebsiella pneumoniae (Kp)-induced increase in p38 expression levels as well as increases in p-p38/p-38 and p-MK2/MK2 levels, in RLE6TN cells.
Cancer Biother Radiopharm

Ultrasound-Responsive Folate-Chlorogenic Acid Nanocarrier Targeting Mixed Lineage Kinase 1 for Enhanced Wilms Tumor Therapy. [Abstract]

2026 Mar 19:10849785261424783. PMID: 41852338
SSRN

2026 May 4.
SSRN

2026 Apr 8.
SSRN

2026 Apr 14.
Research Square Preprint

2023 Dec 23.

용액&용해도

In Vitro:

DMSO : 100 mg/mL (282.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : 20 mg/mL (56.45 mM; ultrasonic and warming and heat to 60°C)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.8224 mL

14.1119 mL

28.2239 mL

5 mM

0.5645 mL

2.8224 mL

5.6448 mL

10 mM

0.2822 mL

1.4112 mL

2.8224 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Working solution concentration: 0.22 mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact

MedChemExpress (MCE) .

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (279 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Park JJ, et al. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway. Cell Oncol (Dordr). 2015 Jan 6. [Content Brief]

[2]. Park SH, et al. IRAK4 as a Molecular Target in the Amelioration of Innate Immunity-Related Endotoxic Shock and Acute Liver Injury by Chlorogenic Acid. J Immunol. 2015 Feb 1;194(3):1122-30. [Content Brief]

[3]. Kang JW, et al. Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats. Biomol Ther (Seoul). 2014 Sep;22(5):420-5. [Content Brief]

[4]. Huang S, et al. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation. Theranostics. 2019 Sep 19;9(23):6745-6763. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
H₂O / DMSO	1 mM	2.8224 mL	14.1119 mL	28.2239 mL	70.5597 mL
	5 mM	0.5645 mL	2.8224 mL	5.6448 mL	14.1119 mL
	10 mM	0.2822 mL	1.4112 mL	2.8224 mL	7.0560 mL
	15 mM	0.1882 mL	0.9408 mL	1.8816 mL	4.7040 mL
	20 mM	0.1411 mL	0.7056 mL	1.4112 mL	3.5280 mL
	25 mM	0.1129 mL	0.5645 mL	1.1290 mL	2.8224 mL
	30 mM	0.0941 mL	0.4704 mL	0.9408 mL	2.3520 mL
	40 mM	0.0706 mL	0.3528 mL	0.7056 mL	1.7640 mL
	50 mM	0.0564 mL	0.2822 mL	0.5645 mL	1.4112 mL
DMSO	60 mM	0.0470 mL	0.2352 mL	0.4704 mL	1.1760 mL
	80 mM	0.0353 mL	0.1764 mL	0.3528 mL	0.8820 mL
	100 mM	0.0282 mL	0.1411 mL	0.2822 mL	0.7056 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Chlorogenic acid

36 Cited Publications

100 mg 견적 받기

Subscribe to the

MedChemExpress

Newsletter

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

Chlorogenic acid

Caffeic acid

Luteolin

Glycyrrhizic acid

Quercetin

(-)-Epigallocatechin Gallate

Ferulic acid

Rutin

Resveratrol

Curcumin

Gallic acid

Cryptochlorogenic acid

Kaempferol

Publications Citing Use of MedChemExpress (MCE) Chlorogenic acid

All HIF/HIF Prolyl-Hydroxylase Isoforms

All Endogenous Metabolite Isoforms

Biological Activity

Chemical Information

Publications (36)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

Chlorogenic acid

Caffeic acid

Luteolin

Glycyrrhizic acid

Quercetin

(-)-Epigallocatechin Gallate

Ferulic acid

Rutin

Resveratrol

Curcumin

Gallic acid

Cryptochlorogenic acid

Kaempferol

Publications Citing Use of MedChemExpress (MCE) Chlorogenic acid

All HIF/HIF Prolyl-Hydroxylase Isoforms

All Endogenous Metabolite Isoforms

Biological Activity

Chemical Information

Publications (36)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

Chlorogenic acid Related Classifications

HY-N0055 Related Classifications